N Cichanowitz
Overview
Explore the profile of N Cichanowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kimball A, Papp K, Reich K, Gooderham M, Li Q, Cichanowitz N, et al.
Br J Dermatol
. 2019 Sep;
182(6):1359-1368.
PMID: 31487406
Background: Chronic psoriasis may require medication adjustments over time. Objectives: To evaluate the efficacy/safety of tildrakizumab in subgroups from the reSURFACE studies (N = 1862) that received continuous dosing, higher/lower...
2.
Papp K, Reich K, Blauvelt A, Kimball A, Gooderham M, Tyring S, et al.
J Eur Acad Dermatol Venereol
. 2019 Mar;
33(6):1098-1106.
PMID: 30838709
Background: Efficacy of tildrakizumab for plaque psoriasis was demonstrated in randomized, placebo-controlled trials. Objective: To consolidate tildrakizumab efficacy results by pooling data. Methods: Data (N = 2081) from tildrakizumab 100...
3.
Blauvelt A, Reich K, Papp K, Kimball A, Gooderham M, Tyring S, et al.
Br J Dermatol
. 2018 May;
179(3):615-622.
PMID: 29742274
Background: Short-term interleukin-23p19 inhibition by tildrakizumab improves plaque psoriasis and appears to be well tolerated. Objectives: Safety and tolerability were assessed for up to 64 weeks of tildrakizumab therapy using...
4.
Puopolo A, Boice J, Fidelholtz J, Littlejohn T, Miranda P, Berrocal A, et al.
Osteoarthritis Cartilage
. 2007 Jul;
15(12):1348-56.
PMID: 17631392
Objective: We compared the efficacy of etoricoxib 30 mg to placebo and ibuprofen 2400 mg for the treatment of osteoarthritis (OA) of the hip and knee. Design: In this 12-week,...